Nobilis TRT Lyophilisate for suspension
Nobilis TRT Lyophilisate for suspension
Not authorised
- Turkey rhinotracheitis virus, strain BUT1#8544, Live
Product identification
Medicine name:
Nobilis TRT Lyophilisate for suspension
Active substance:
- Turkey rhinotracheitis virus, strain BUT1#8544, Live
Target species:
-
Turkey
Route of administration:
-
Nebulisation use
-
Intraocular use
-
Nasal use
Product details
Active substance and strength:
-
Turkey rhinotracheitis virus, strain BUT1#8544, Live0.40/50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for oculonasal suspension
Withdrawal period by route of administration:
-
Nebulisation use
-
Turkey
-
Meat and offal0day
-
-
-
Intraocular use
-
Turkey
-
Meat and offal0day
-
-
-
Nasal use
-
Turkey
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01CD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Germany
Package description:
- (ID4): 1 Box with (1 Bottle (Glass) with 5000 Dose and 1 Bottle (-) with 0 millilitre(s)) (5000.0 Dose, 0.0 millilitre(s))
- (ID3): 1 Box with (1 Bottle (Glass) with 2500 Dose and 1 Bottle (-) with 0 millilitre(s)) (2500.0 Dose, 0.0 millilitre(s))
- (ID2): 1 Box with (1 Bottle (Glass) with 1000 Dose and 1 Bottle (-) with 0 millilitre(s)) (1000.0 Dose, 0.0 millilitre(s))
- (ID1): 1 Box with (1 Bottle (Glass) with 500 Dose and 1 Bottle (-) with 0 millilitre(s)) (500.0 Dose, 0.0 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
- MERCK SHARP & DOHME ANIMAL HEALTH, S.L.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 189a/95
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0205/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/02/2022